VCU biology professor receives $1.3M grant to study membrane transport pathways in yeast “We are interested in understanding the different ways that cells internalize material,” said Derek Prosser, an assistant professor in the Department of Biology. Read more »
VCU experts in nanomedicine and gene therapy work toward promising cardiovascular disease treatment Their research efforts focus on decreasing the risk of heart attack or stroke by reducing plaque in the artery walls. Read more »
First investigational drug therapy for liver disease NASH awaiting FDA approval Global clinical trial designed in collaboration with VCU successfully tested a drug therapy to treat the chronic liver disease. Read more »
Researchers honored for noninvasive eye-tracking system Innovators took ‘something that is inherently difficult and made it as simple as possible.’ Read more »
Working-age Americans dying at higher rates, especially in economically hard-hit states A new VCU study identifies “a distinctly American phenomenon” as mortality among 25 to 64 year-olds increases and U.S. life expectancy continues to fall. Read more »
Cost of care biggest barrier for previously uninsured Medicaid members, VCU study finds Virginia is the first to conduct a survey of newly eligible members to understand their health care experiences prior to enrolling in Medicaid. 1/14/2020
VCU biology professor receives $1.3M grant to study membrane transport pathways in yeast “We are interested in understanding the different ways that cells internalize material,” said Derek Prosser, an assistant professor in the Department of Biology. 1/9/2020
An often-made claim that e-cigarettes are ‘95% safer’ is not valid Thomas Eissenberg of the Center for the Study of Tobacco Products at VCU was one of six experts who investigated the claim and found it unreliable and outdated. 1/8/2020
Year in review 2019: A look back at VCU’s top stories, Instagram pics, videos and more 2019 was a very full year for Virginia Commonwealth University. 1/7/2020
VCU experts in nanomedicine and gene therapy work toward promising cardiovascular disease treatment Their research efforts focus on decreasing the risk of heart attack or stroke by reducing plaque in the artery walls. 12/11/2019
Medicines for All Institute co-founder elected as National Academy of Inventors fellow B. Frank Gupton will be inducted during an April 2020 ceremony at the Heard Museum in Arizona. 12/9/2019
First investigational drug therapy for liver disease NASH awaiting FDA approval Global clinical trial designed in collaboration with VCU successfully tested a drug therapy to treat the chronic liver disease. 12/6/2019
Researchers honored for noninvasive eye-tracking system Innovators took ‘something that is inherently difficult and made it as simple as possible.’ 11/26/2019
A team of Virginia Commonwealth University researchers, led by the VCU School of Medicine’s Department of Health Behavior and Policy, conducted a baseline survey among 1,500 newly eligible Medicaid members in Virginia. Andrew Barnes, Ph.D., associate professor of health behavior and policy, talked to VCU News about the study, which is part of a larger Medicaid expansion evaluation VCU is conducting on behalf of the Department of Medical Assistance Services. Read more »